Tove Sivik

C–X–C ligand 10 and C–X–C receptor 3 status can predict tamoxifen treatment response in breast cancer patients

O. Stål, B. Nordenskjöld, T. Fornander, 2014, Breast Cancer Research and Treatment.

in normal physiology and in breast cancer

T. Sivik, Tove Sivik, 2012 .

Progesterone and levonorgestrel regulate expression of 17βHSD-enzymes in progesterone receptor positive breast cancer cell line T47D.

A. Jansson, Tove Sivik, 2012, Biochemical and biophysical research communications.

Expression Patterns of 17β-Hydroxysteroid Dehydrogenase 14 in Human Tissues

S. Vikingsson, A. Jansson, T. Sivik, 2012, Hormone and Metabolic Research.

17β-Hydroxysteroid Dehydrogenase Type 14 Is a Predictive Marker for Tamoxifen Response in Oestrogen Receptor Positive Breast Cancer

L. Skoog, O. Stål, B. Nordenskjöld, 2012, PloS one.